Given that the pro-angiogenic activities of ahNSCs are one of the treatment mechanisms for ischemic stroke, it was determined whether the JAK2/STAT3 signaling pathway is also involved in the pro-angiogenic activities of NSC-CM using endothelial cells (HUVECs). This evidence concerns the gene JAK2 and ischemic stroke.